资讯

Since the FDA approved Botox’s indication for chronic migraines in 2010, Allergan has been promoting it via traditional DTC and sales-force-led professional efforts. But such efforts reached a ...
Allergan plc <AGN.N> said on Wednesday that its Botox blockbuster wrinkle treatment just missed achieving a significant improvement in treating depression in a mid-stage trial, but it found the ...
Allergan's plan to grow its Botox and fillers businesses relies in large part on getting millennials to use its products. The drug company is launching a handful of millennial-focused campaigns ...
Allergan Inc <AGN.N> said on Thursday that its popular Botox facial wrinkle-smoother worked as a treatment for adults suffering from chronic migraines, according to late-stage clinical data.
The company behind Botox, the "face-lift in a bottle," is itself aging rather gracefully. Net sales increased by 13.3%, to roughly $1.3 billion, in the first quarter of 2011 compared with the same ...
FORTUNE -- Allergan is in a tough spot. It manufactures Botox, the blockbuster cosmetic product that's made with a diluted form of the most potent toxin on the planet. America's favorite smile ...
Abbvie spun off from Abbott Laboratories in 2013. Allergan had been expected to consider a potential split amid looming competition for wrinkle treatment Botox, according to Mizuho Securities ...
The transaction is currently valued at $363.63 per Allergan share, for a total enterprise value of roughly $160 billion, including debt, based on the $32.18 per share closing price of Pfizer stock ...
In 2001, sales of Botox had barely passed three hundred million dollars; by 2013, sales were nearing two billion dollars and accounted for almost a third of Allergan’s revenue.
A happy coincidence put data in front of Allergan’s aesthetics marketing team that proved Botox appointments spiked around the holidays. The research showed that November 20 is the busiest day of the ...
A single injection of Allergan Inc.’s Botox into a woman’s bladder reduces urinary incontinence as effectively as daily drugs and is better at resolving the problem, a U.S. government-funded ...